REGULATORY INTELLIGENCE·Recall
FDA Class II Recall: Teva Pharmaceuticals' Warfarin Sodium Affected by Cardinal Healthcare Storage Deviations
Teva Pharmaceuticals USA, Inc.'s Warfarin Sodium Tablets faced a Class II recall initiated by CARDINAL HEALTHCARE due to CGMP deviations involving temperature excursions during storage. This event, now terminated, underscores critical supply chain vulnerabilities for procurement and regulatory teams, demanding rigorous oversight of distributor storage protocols for sensitive pharmaceuticals.
90-Day Activity